These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18596151)

  • 1. Heat shock protein 90 modulates LRRK2 stability: potential implications for Parkinson's disease treatment.
    Hurtado-Lorenzo A; Anand VS
    J Neurosci; 2008 Jul; 28(27):6757-9. PubMed ID: 18596151
    [No Abstract]   [Full Text] [Related]  

  • 2. The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.
    Wang L; Xie C; Greggio E; Parisiadou L; Shim H; Sun L; Chandran J; Lin X; Lai C; Yang WJ; Moore DJ; Dawson TM; Dawson VL; Chiosis G; Cookson MR; Cai H
    J Neurosci; 2008 Mar; 28(13):3384-91. PubMed ID: 18367605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
    Plowey ED; Cherra SJ; Liu YJ; Chu CT
    J Neurochem; 2008 May; 105(3):1048-56. PubMed ID: 18182054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP.
    Ding X; Goldberg MS
    PLoS One; 2009 Jun; 4(6):e5949. PubMed ID: 19536328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?
    Gillardon F
    J Neurochem; 2009 Sep; 110(5):1514-22. PubMed ID: 19545277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-synuclein and LRRK2: partners in crime.
    Tong Y; Shen J
    Neuron; 2009 Dec; 64(6):771-3. PubMed ID: 20064381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activity.
    Lichtenberg M; Mansilla A; Zecchini VR; Fleming A; Rubinsztein DC
    Cell Death Dis; 2011 Aug; 2(8):e196. PubMed ID: 21866175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.
    West AB; Moore DJ; Choi C; Andrabi SA; Li X; Dikeman D; Biskup S; Zhang Z; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2007 Jan; 16(2):223-32. PubMed ID: 17200152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis.
    Ohta E; Kubo M; Obata F
    Biochem Biophys Res Commun; 2010 Jan; 391(1):242-7. PubMed ID: 19912990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein 90 functions to stabilize and activate the testis-specific serine/threonine kinases, a family of kinases essential for male fertility.
    Jha KN; Coleman AR; Wong L; Salicioni AM; Howcroft E; Johnson GR
    J Biol Chem; 2013 Jun; 288(23):16308-16320. PubMed ID: 23599433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 and neurodegeneration.
    Santpere G; Ferrer I
    Acta Neuropathol; 2009 Mar; 117(3):227-46. PubMed ID: 19142648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 as a therapeutic target in Parkinson's disease.
    Tan EK; Schapira AH
    Eur J Neurol; 2011 Apr; 18(4):545-6. PubMed ID: 21199179
    [No Abstract]   [Full Text] [Related]  

  • 13. A trojan horse for Parkinson's disease.
    Hu Y; Tong Y
    Sci Signal; 2010 Apr; 3(116):pe13. PubMed ID: 20371768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity.
    Ko HS; Bailey R; Smith WW; Liu Z; Shin JH; Lee YI; Zhang YJ; Jiang H; Ross CA; Moore DJ; Patterson C; Petrucelli L; Dawson TM; Dawson VL
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2897-902. PubMed ID: 19196961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
    Daher JP
    Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 Parkinson's disease: from animal models to cellular mechanisms.
    Lin CH; Tsai PI; Wu RM; Chien CT
    Rev Neurosci; 2011; 22(4):411-8. PubMed ID: 21679126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.
    Greggio E
    Biochem Soc Trans; 2012 Oct; 40(5):1058-62. PubMed ID: 22988865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.
    Gandhi PN; Chen SG; Wilson-Delfosse AL
    J Neurosci Res; 2009 May; 87(6):1283-95. PubMed ID: 19025767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 in Parkinson's disease: building an understanding of disease etiology.
    Braithwaite SP
    FEBS J; 2009 Nov; 276(22):6427. PubMed ID: 19804417
    [No Abstract]   [Full Text] [Related]  

  • 20. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function.
    Basso AD; Solit DB; Chiosis G; Giri B; Tsichlis P; Rosen N
    J Biol Chem; 2002 Oct; 277(42):39858-66. PubMed ID: 12176997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.